232 related articles for article (PubMed ID: 29858532)
1. Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period.
Winkelmann A; Rommer PS; Hecker M; Zettl UK
CNS Neurosci Ther; 2019 Jan; 25(1):78-85. PubMed ID: 29858532
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.
Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R
J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.
Bsteh G; Algrang L; Hegen H; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2020 Jan; 26(1):69-78. PubMed ID: 30507345
[TBL] [Abstract][Full Text] [Related]
4. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis.
Haas J; Hommes OR
Mult Scler; 2007 Aug; 13(7):900-8. PubMed ID: 17881400
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
Dudesek A; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754
[TBL] [Abstract][Full Text] [Related]
6. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
Brandt-Wouters E; Gerlach OH; Hupperts RM
Int J Gynaecol Obstet; 2016 Aug; 134(2):194-6. PubMed ID: 27177509
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis.
Sorensen PS; Fazekas F; Lee M
Eur J Neurol; 2002 Nov; 9(6):557-63. PubMed ID: 12453069
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and multiple sclerosis: a 2-year experience.
Orvieto R; Achiron R; Rotstein Z; Noy S; Bar-Hava I; Achiron A
Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):191-4. PubMed ID: 10206414
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis.
Horvat Ledinek A; Brecl Jakob G; Jerše J; Ruška B; Pavičić T; Gabelić T; Barun B; Adamec I; Rot U; Šega Jazbec S; Krbot Skorić M; Habek M
Mult Scler Relat Disord; 2020 Feb; 38():101519. PubMed ID: 31756610
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
Sørensen PS
Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
[TBL] [Abstract][Full Text] [Related]
11. IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
Bayry J; Hartung HP; Kaveri SV
Trends Pharmacol Sci; 2015 Jul; 36(7):419-21. PubMed ID: 26003802
[TBL] [Abstract][Full Text] [Related]
12. Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy.
Hellwig K; Tokic M; Thiel S; Esters N; Spicher C; Timmesfeld N; Ciplea AI; Gold R; Langer-Gould A
JAMA Netw Open; 2022 Jan; 5(1):e2144750. PubMed ID: 35072719
[TBL] [Abstract][Full Text] [Related]
13. Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelsztejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Salgado PR; Siquineli F; Souza DB; Tosta ED; Vasconcelos CC; Almeida SM; Bernardes DF; Castro SN; Gama RA; Gomide FA; Finkelzstejn J; Lopes J; Lourenco FH; Lourenco GA; Oliveira CL; Oliveira FT; Oliveira LF; Patroclo CB; Pereira WL; Safanelli J; Sahdo AM; Saldanha PC; Shinzato YF; Souza JM; Zani DE
Health Care Women Int; 2015; 36(10):1072-80. PubMed ID: 25187102
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study.
Fares J; Nassar AH; Gebeily S; Kobeissy F; Fares Y
BMJ Open; 2016 May; 6(5):e011210. PubMed ID: 27178979
[TBL] [Abstract][Full Text] [Related]
15. Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Vukusic S; Durand-Dubief F; Benoit A; Marignier R; Frangoulis B; Confavreux C
Mult Scler; 2015 Jun; 21(7):953-5. PubMed ID: 25305253
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation and postpartum relapses in patients with multiple sclerosis.
Hellwig K; Beste C; Schimrigk S; Chan A
Ther Adv Neurol Disord; 2009 Jan; 2(1):7-11. PubMed ID: 21180639
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and reproductive risks in women.
Argyriou AA; Makris N
Reprod Sci; 2008 Oct; 15(8):755-64. PubMed ID: 19017813
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy in Multiple Sclerosis: A Portuguese cohort study.
Jesus-Ribeiro J; Correia I; Martins AI; Fonseca M; Marques I; Batista S; Nunes C; Macário C; Almeida MC; Sousa L
Mult Scler Relat Disord; 2017 Oct; 17():63-68. PubMed ID: 29055477
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy.
Saraste M; Väisänen S; Alanen A; Airas L;
Gend Med; 2007 Mar; 4(1):45-55. PubMed ID: 17584627
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis.
Menascu S; Siegel-Kirshenbaum M; Dreyer-Alster S; Warszawer Y; Magalashvili D; Dolev M; Mandel M; Harari G; Achiron A
Mult Scler J Exp Transl Clin; 2023; 9(1):20552173221151127. PubMed ID: 36687367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
